EHA2024 Congress Closed European Hematology Association Annual Congress Dates: Thursday, June 13, 2024 - Sunday, June 16, 2024 Venue: IFEMA Madrid,Madrid,Spain EHA is excited to welcome you in-person in Madrid, Spain from June 13-16, 2024....
会议官网:https://www.ebmt.org/annual-meeting-2024 03 2024年第64届英国血液学会年会(BSH 2024) 会议主办方:英国血液学会 会议时间:4月28日-4月30日 会议地点:英国-ACC利物浦 会议官网:https://bshconferences.co.uk/ 6月 01 2024年美国临床肿瘤学会年会(ASCO 2024) 会议主办方:美国临床肿瘤学会 会议时间:...
European Hematology Association Annual Congress Dates: Thursday, June 12, 2025 - Sunday, June 15, 2025 Venue: Allianz MiCo,Milan,Italy Join us for the 30th EHA Congress, taking place from June 12-15, 2025, as we revolutionize the way we learn and connect in Hematology! Our team has worked...
GSK will be at the European Hematology Association (EHA) annual meeting 2023. Date: 8-11 June Location: Frankfurt, GermanyGSK at EHA 2023 Patient stories Targetting a better future Behind the science This June, at the European Hematology Association (EHA) annual meeting, we will share...
The Annual Congress of EHA is a flagship meeting held in a major European city every June—a significant meeting place for hematologists from every area of specialization. Our annual congresses encompass the entire spectrum of hematological studies, where you, together with 11,000 other participants...
This abstract is embargoed until 23.05.2024 23:00 CEST, until publication by the American Society of Clinical Oncology, Inc. for their 2024 ASCO Annual Meeting. The Abstract PB3041,“A Phase 1/2 trial investigating safety, tolerability, and preliminary antitumor activity of IPH6501, a first-i...
(NGS)-based clonoSEQ®test for measurable residual disease (MRD) assessment will be included in several oral and poster presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place May 31-June 4 in Chicago and at the European Hematology Association (EHA) Hybrid ...
Johnson & Johnson presentations at ASCO 2024 Annual Meeting: Lung Cancer Oral Presentations Abstract #8504 Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer (NSCLC) with biomarkers...
June 11–21, 2020 Save to your areas of interest DECIDER study: The addition of all-trans retinoic acid to decitabine improves survival in elderly patients with AML During the 25th European Hematology Association (EHA) Annual Congress, 2020, Michael... ...
Following this year's American Society of Clinical Oncology (ASCO) Annual Meeting and during the 25th Congress of the European Hematology Association... Jun 18, 2020 |EHA 2020 Jun 16, 2020 |EHA 2020 All Events European Lymphoma Institute Workshop ...